Raymond James & Associates Teva Pharmaceutical Industries LTD Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Raymond James & Associates holds 1,020,719 shares of TEVA stock, worth $22.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,020,719
Previous 815,944 25.1%
Holding current value
$22.9 Million
Previous $13.3 Million 38.72%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$15.81 - $18.96 $3.24 Million - $3.88 Million
204,775 Added 25.1%
1,020,719 $18.4 Million
Q2 2024

Jul 19, 2024
BUY
$12.78 - $17.4 $506,215 - $689,214
39,610 Added 5.1%
815,944 $13.3 Million
Q1 2024

Apr 22, 2024
BUY
$10.67 - $14.43 $6.08 Million - $8.22 Million
569,621 Added 275.56%
776,334 $11 Million
Q4 2023

Jan 16, 2024
BUY
$8.12 - $10.63 $39,666 - $51,927
4,885 Added 2.42%
206,713 $2.16 Million
Q3 2023

Oct 24, 2023
SELL
$7.48 - $10.7 $107,906 - $154,358
-14,426 Reduced 6.67%
201,828 $2.06 Million
Q2 2023

Jul 25, 2023
SELL
$7.2 - $9.47 $153,727 - $202,193
-21,351 Reduced 8.99%
216,254 $1.63 Million
Q1 2023

Apr 14, 2023
BUY
$8.36 - $11.37 $184,329 - $250,697
22,049 Added 10.23%
237,605 $2.1 Million
Q4 2022

Feb 08, 2023
SELL
$7.95 - $9.48 $156,750 - $186,917
-19,717 Reduced 8.38%
215,556 $1.97 Million
Q3 2022

Oct 25, 2022
SELL
$6.86 - $11.95 $266,696 - $464,580
-38,877 Reduced 14.18%
235,273 $1.9 Million
Q2 2022

Aug 12, 2022
SELL
$7.38 - $10.4 $198,182 - $279,281
-26,854 Reduced 8.92%
274,150 $2.06 Million
Q1 2022

May 11, 2022
SELL
$7.33 - $9.39 $173,024 - $221,650
-23,605 Reduced 7.27%
301,004 $2.83 Million
Q4 2021

Feb 08, 2022
SELL
$7.9 - $10.19 $567,093 - $731,478
-71,784 Reduced 18.11%
324,609 $2.6 Million
Q3 2021

Nov 02, 2021
SELL
$8.38 - $10.18 $622,617 - $756,353
-74,298 Reduced 15.78%
396,393 $3.86 Million
Q2 2021

Aug 11, 2021
SELL
$9.9 - $11.56 $856,221 - $999,789
-86,487 Reduced 15.52%
470,691 $4.66 Million
Q1 2021

May 14, 2021
SELL
$10.34 - $12.81 $1.8 Million - $2.23 Million
-174,271 Reduced 23.83%
557,178 $6.43 Million
Q4 2020

Feb 12, 2021
BUY
$8.61 - $11.04 $2.02 Million - $2.59 Million
234,643 Added 47.23%
731,449 $7.06 Million
Q3 2020

Nov 04, 2020
SELL
$8.57 - $12.69 $886,540 - $1.31 Million
-103,447 Reduced 17.23%
496,806 $4.48 Million
Q2 2020

Jul 28, 2020
SELL
$8.12 - $13.12 $773,365 - $1.25 Million
-95,242 Reduced 13.69%
600,253 $7.4 Million
Q1 2020

Apr 21, 2020
BUY
$6.69 - $13.45 $894,392 - $1.8 Million
133,691 Added 23.8%
695,495 $6.25 Million
Q4 2019

Feb 12, 2020
SELL
$6.53 - $10.72 $654,423 - $1.07 Million
-100,218 Reduced 15.14%
561,804 $5.51 Million
Q3 2019

Nov 07, 2019
SELL
$6.16 - $9.6 $49,852 - $77,692
-8,093 Reduced 1.21%
662,022 $4.56 Million
Q2 2019

Aug 06, 2019
BUY
$8.12 - $15.72 $1.34 Million - $2.59 Million
164,720 Added 32.59%
670,115 $6.19 Million
Q1 2019

May 06, 2019
BUY
$15.58 - $20.01 $71,075 - $91,285
4,562 Added 0.91%
505,395 $7.93 Million
Q4 2018

Feb 11, 2019
SELL
$14.59 - $23.84 $1.67 Million - $2.72 Million
-114,205 Reduced 18.57%
500,833 $7.72 Million
Q3 2018

Nov 14, 2018
BUY
$21.06 - $25.65 $98,413 - $119,862
4,673 Added 0.77%
615,038 $13.2 Million
Q2 2018

Aug 14, 2018
SELL
$16.77 - $24.71 $1.94 Million - $2.85 Million
-115,500 Reduced 15.91%
610,365 $14.8 Million
Q1 2018

May 14, 2018
BUY
$16.68 - $22.07 $249,065 - $329,549
14,932 Added 2.1%
725,865 $12.4 Million
Q4 2017

Feb 14, 2018
BUY
$11.23 - $19.1 $1.25 Million - $2.13 Million
111,263 Added 18.55%
710,933 $13.5 Million
Q3 2017

Nov 13, 2017
BUY
$15.41 - $32.17 $1.74 Million - $3.63 Million
112,822 Added 23.17%
599,670 $10.6 Million
Q2 2017

Aug 14, 2017
BUY
N/A
486,848
486,848 $16.2 Million

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email